Literature DB >> 9225768

Trypanosoma brucei: lack of cross-resistance to melarsoprol in vitro by cymelarsan-resistant parasites.

A G Scott1, A Tait, C M Turner.   

Abstract

We have examined cross-resistance between trypanocidal drugs using a well-characterised drug-sensitive line, 247, and its cymelarsan-resistant derivative, 247melCyR. The cymelarsan-resistant line was cross-resistant to trimelarsen and melarsen oxide, and partially cross-resistant to two diamidines, pentamidine and berenil (diminazene aceturate). It was cross-resistant to lipid-soluble melarsoprol in vivo but to only a trivial degree in two in vitro assays. The potential role of adenosine transport in arsenical-induced killing of parasites was investigated. Adenosine, adenine, and the diamidines, but not inosine, were able to inhibit killing of drug-sensitive STIB 247 trypanosomes by cymelarsan and melarsen oxide in a concentration-dependent manner. These results are consistent with the view that these arsenical compounds enter trypanosomes via an adenosine-specific transporter. Melarsoprol-induced killing of trypanosomes was unaffected, however, by either purine and to only a slight degree by the diamidines. These data suggest that melarsoprol can enter trypanosomes by a route other than through an adenosine transporter and that there may be two mechanisms contributing to arsenical resistance in this drug-resistant line of trypanosomes.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9225768     DOI: 10.1006/expr.1997.4167

Source DB:  PubMed          Journal:  Exp Parasitol        ISSN: 0014-4894            Impact factor:   2.011


  10 in total

1.  Novel alkylpolyamine analogues that possess both antitrypanosomal and antimicrosporidial activity.

Authors:  Y Zou; Z Wu; N Sirisoma; P M Woster; R A Casero; L M Weiss; D Rattendi; S Lane; C J Bacchi
Journal:  Bioorg Med Chem Lett       Date:  2001-06-18       Impact factor: 2.823

2.  Contribution of dithiol ligands to in vitro and in vivo trypanocidal activities of dithiaarsanes and investigation of ligand exchange in an aqueous solution.

Authors:  P M Loiseau; P Lubert; J G Wolf
Journal:  Antimicrob Agents Chemother       Date:  2000-11       Impact factor: 5.191

3.  Multiple genetic mechanisms lead to loss of functional TbAT1 expression in drug-resistant trypanosomes.

Authors:  Mhairi L Stewart; Richard J S Burchmore; Caroline Clucas; Christiane Hertz-Fowler; Karen Brooks; A Tait; A Macleod; C Michael R Turner; Harry P De Koning; Pui Ee Wong; Michael P Barrett
Journal:  Eukaryot Cell       Date:  2009-12-04

4.  Mechanisms of arsenical and diamidine uptake and resistance in Trypanosoma brucei.

Authors:  Enock Matovu; Mhairi L Stewart; Federico Geiser; Reto Brun; Pascal Mäser; Lynsey J M Wallace; Richard J Burchmore; John C K Enyaru; Michael P Barrett; Ronald Kaminsky; Thomas Seebeck; Harry P de Koning
Journal:  Eukaryot Cell       Date:  2003-10

5.  The trypanocide diminazene aceturate is accumulated predominantly through the TbAT1 purine transporter: additional insights on diamidine resistance in african trypanosomes.

Authors:  Harry P de Koning; Laura F Anderson; Mhairi Stewart; Richard J S Burchmore; Lynsey J M Wallace; Michael P Barrett
Journal:  Antimicrob Agents Chemother       Date:  2004-05       Impact factor: 5.191

Review 6.  Arsenicals (melarsoprol), pentamidine and suramin in the treatment of human African trypanosomiasis.

Authors:  Andrew Jonathan Nok
Journal:  Parasitol Res       Date:  2003-01-31       Impact factor: 2.289

Review 7.  Human African trypanosomiasis: pharmacological re-engagement with a neglected disease.

Authors:  M P Barrett; D W Boykin; R Brun; R R Tidwell
Journal:  Br J Pharmacol       Date:  2007-07-09       Impact factor: 8.739

8.  In vivo imaging of trypanosome-brain interactions and development of a rapid screening test for drugs against CNS stage trypanosomiasis.

Authors:  Elmarie Myburgh; Jonathan A Coles; Ryan Ritchie; Peter G E Kennedy; Alex P McLatchie; Jean Rodgers; Martin C Taylor; Michael P Barrett; James M Brewer; Jeremy C Mottram
Journal:  PLoS Negl Trop Dis       Date:  2013-08-22

Review 9.  Laboratory Selection of Trypanosomatid Pathogens for Drug Resistance.

Authors:  Sabina Beilstein; Radhia El Phil; Suzanne Sherihan Sahraoui; Leonardo Scapozza; Marcel Kaiser; Pascal Mäser
Journal:  Pharmaceuticals (Basel)       Date:  2022-01-24

10.  Trypanosoma brucei aquaglyceroporin 2 is a high-affinity transporter for pentamidine and melaminophenyl arsenic drugs and the main genetic determinant of resistance to these drugs.

Authors:  Jane C Munday; Anthonius A Eze; Nicola Baker; Lucy Glover; Caroline Clucas; David Aguinaga Andrés; Manal J Natto; Ibrahim A Teka; Jennifer McDonald; Rebecca S Lee; Fabrice E Graf; Philipp Ludin; Richard J S Burchmore; C Michael R Turner; Andy Tait; Annette MacLeod; Pascal Mäser; Michael P Barrett; David Horn; Harry P De Koning
Journal:  J Antimicrob Chemother       Date:  2013-11-13       Impact factor: 5.790

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.